The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Progenics Pharmaceuticals Inc.  (PGNX) Trade Now »     Rate PGNX  -  Discuss PGNX  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate PGNX:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

PGNX: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

From the Blogosphere

A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes

On Wednesday (Nov. 18), Progenic's Pharmaceutical (PGNX), received some good news in the form of a Reuters story stating that the widely-used painkiller drug, morphine, may actually accelerate cancer growth in patients. Researchers in the US have results from two studies that show that morphine could be on the wrong side of the fight against cancer. But PGNX's drug, Relistor, has shown promise in reversing some of the tumor-generating effects in mice and, significantly, in lung cancer cells.

<>The article also quoted Patrick SIngleton of the University of Chicago Medical Center, who remarked o...
By  trackseekingalpha   (-11.17%  risk: aggressive)  11/20/09 Comment


Analyst downgrades: Concur Tech, Groupe Danone, General Motors

Filed under: Analyst reports, Analyst upgrades and downgrades, General Motors (GM), UAL Corp (UAUA)

MOST NOTEWORTHY: Concur Tech, Groupe Danone and General Motors were today's noteworthy downgrades:

<>
  • Piper downgraded shares of Concur Tech (NASDAQ: CNQR) to Neutral from Buy after transferring analyst coverage, as they believe potential upside to estimates is priced into shares while competitive concerns from American Express (NYSE: AXP) are not.
    • <>Morgan Stanley downgraded shares of Groupe Danone (OTC: GDNNY) to Equal Weight from Overweight to reflect reduced visibility in the company's...
    By  Eric Buscemi   (+0.00%)  07/02/08 Comment


    Monday's Upgrades and Downgrades
     2 %
    <>
    Upgrades
    Wright Medical (WMGI)- Leerink Swann Mkt Perform » Outperform
    Axsys Technologies (AXYS)- Boenning & Scattergood Market Perform » Market Outperform
    Trimble Navigation (TRMB)- Piper Jaffray Neutral » Buy
    Emulex (ELX)- Morgan Keegan Mkt Perform » Outperform
    Synovus (SNV)- Bernstein Mkt Perform » Outperform
    Health Management (HMA)- Credit Suisse Neutral » Outperform
    Tenet Healthcare (THC)- Credit Suisse Neutral » Outperform
    Northrop Grumman (NOC)- Cowen & Co Neutral » Outperform
    Sohu.com (SOHU)- Citigroup Hold » Buy
    Progenics Pharm (PGNX)- Ci...
    By  Todd Sullivan   (-25.49%  risk: aggressive)  04/28/08 Comment


    Monday's Upgrades and Downgrades
    <>
    Upgrades
    Wright Medical (WMGI)- Leerink Swann Mkt Perform » Outperform
    Axsys Technologies (AXYS)- Boenning & Scattergood Market Perform » Market Outperform
    Trimble Navigation (TRMB)- Piper Jaffray Neutral » Buy
    Emulex (ELX)- Morgan Keegan Mkt Perform » Outperform
    Synovus (SNV)- Bernstein Mkt Perform » Outperform
    Health Management (HMA)- Credit Suisse Neutral » Outperform
    Tenet Healthcare (THC)- Credit Suisse Neutral » Outperform
    Northrop Grumman (NOC)- Cowen & Co Neutral » Outperform
    Sohu.com (SOHU)- Citigroup Hold » Buy
    Progenics Pharm (PGNX)- Ci...
    By  Todd Sullivan   (+0.00%)  04/28/08 Comment


    Pre-Open Movers 2/25:Progenics Pharma (PGNX) Jumps On FDA Approval, Netgear (NTGR) Down on Results
    <>StreetInsider.com Pre-Open Movers:

    Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) 23% HIGHER; Progenics and Wyeth (NYSE: WYE) announced that the FDA has approved RELISTOR subcutaneous injection for the treatment of opioid-induced constipation in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient.

    ISIS Pharmaceuticals Inc. (Nasdaq: ISIS) 23% LOWER; The FDA has provided guidance regarding approval requirements for mipomersen. The FDA has indicated that reduction of LDL-cholesterol is an acceptable surrogate endpoint for ...
    By  Street Insider   (+9.67%  risk: moderate)  04/25/08 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +34.25% 381
    2 Gerald Greene 18.14 +72.34% 210
    3 stockmarketfunding.com 17.66 +25.65% 55
    4 akiralegrand 13.47 +14.32% 62
    5 anup2104 12.13 +76.91% 39


    POPULAR STOCKS
    Symbol Company Name Sentiment
    JNJ Johnson & Johnson
    BIDU Baiducom Inc ADS
    T AT&T Inc
    NVDA NVIDIA Corp
    FSLR First Solar Inc.
    MO Altria Group Inc

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on PGNX

    Visit streetinsider.com


    Discussion Wall + Add  

    Be the first to start a discussion and earn 2 points.



    More Resources

    Graphic_arrow1 About Progenics Pharmaceuticals Inc. - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch